ST

Suresh Tiwari

Active Director Director DIN 09842768
DIN 09842768 First appointment Dec 2022 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Suresh Tiwari

Data last updated:

Suresh Tiwari is a Director at Pty Pharmaceutical Private Limited (since 2022). The company operates in Pharma.

DIN 09842768
Primary Designation Director
Industry Pharma
First Appointment 29 Dec 2022
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pty Pharmaceutical Private Limited U24290DL2022PTC409113
Director29 Dec 20222022Active

Board colleagues of Suresh Tiwari

NameDINCompanyDesignation
Virendra Kumar Tiwari09842767Pty Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Pty Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Suresh Tiwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suresh Tiwari

Suresh Tiwari currently holds 1 directorship: Pty Pharmaceutical Private Limited (Director, since 29 Dec 2022).

Suresh Tiwari was first appointed on 29 Dec 2022 as Director at Pty Pharmaceutical Private Limited.

The current boards of Suresh Tiwari's companies include Virendra Kumar Tiwari (Pty Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available